Hirotaka Tanaka

This inventor holds 22 USPTO granted patents, plus 5 CIPO patents and 10 EPO patents, primarily in Biosensor Technology. Top assignees: Panasonic Corporation, Pfizer Corporation, Matsushita Electric Industrial Co., Ltd.. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirotaka Tanaka. Retrieved from https://idiyas.com/inventor/hirotaka-tanaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22

% Patents Active = 50.0

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 1)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 142(Granted Patents)

Location History:

Matsuyama, JP (2006 - 2010)
Aichi-ken, JP (2009 - 2011)
Chita-gun, JP (2012)
Tokyo-to, JP (2014)
Ehime, JP (2002 - 2015)
Osaka, JP (2021 - 2023)

Company Filing History:

6 out of 16,454

Panasonic Corporation

Matsushita Electric Industrial Co., Ltd.

patents

4. 2 out of 846

Otsuka Pharmaceutical Company, Limited

patents

5. 2 out of 81

Panasonic Healthcare Co., Ltd.

Panasonic Healthcare Holdings Co., Ltd.

patents

Years Active: 2002-2023

Loading Chart...

Areas of Expertise:

Benzazepine Derivatives

Biosensor

Hemoglobin Measurement

Chromatography

Agglutinating Reagent

Measurement Kit

Blood Component Analysis

Electron Microscope

Quantitative Measurement

Receptor Antagonists

Liquid Homogenizer

Analytical Device

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11673878 - Benzazepine derivatives (2023-06-13),

2. 10889570 - Benzazepine derivatives (2021-01-12),

3. 9151765 - Method for producing agglutinating reagent, agglutinating reagent or product produced thereby, and method for measuring analysis object using the same, and test kit and analysis device (2015-10-06),

4. 8956879 - Analysis device and method using the same (2015-02-17),

5. 8921052 - Hemoglobin derivative measurement method, and reagent composition, measurement kit, analysis device and analysis system for use in the method (2014-12-30),

6. 8692194 - Electron microscope device (2014-04-08),

7. 8574913 - Method for measurement of hemoglobin and hemoglobin derivative, and measurement kit (2013-11-05),

8. 8178558 - Substituted pyridylmethyl bicycliccarboxyamide compounds (2012-05-15),

9. 8158650 - Substituted phenylmethyl bicyclocarboxyamide compounds (2012-04-17),

10. 8134004 - Substituted N-bicyclicalkyl bicycliccarboxyamide compounds (2012-03-13),

11. 7998752 - Biosensor and blood component analytical method (2011-08-16),

12. 7915448 - Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists (2011-03-29),

13. 7915051 - Biosensor and blood component analytical method (2011-03-29),

14. 7790439 - Biosensor and measurement method (2010-09-07),

15. 7754151 - Liquid homogenizer and analyzer employing the same (2010-07-13),

Title: The Innovative Journey of Hirotaka Tanaka

Introduction

Hirotaka Tanaka, an esteemed inventor based in Ehime, Japan, has made significant contributions to the field of analytical technology. With a record of 13 patents to his name, his work focuses on improving the reliability and accuracy of hemoglobin measurement methods, which are crucial in various medical applications.

Latest Patents

Tanaka's latest inventions include a comprehensive method for producing an agglutinating reagent and a sophisticated test kit aimed at analyzing hemoglobin in sample solutions. His innovative method denatures hemoglobin quickly and reliably while enabling precise measurement of hemoglobin and its derivatives. The technique involves treating a sample solution containing blood components with nonionic surfactants, oxidizing agents, and metal salts to facilitate accurate hemoglobin measurement. This is then followed by an immunological method that measures the amount of hemoglobin derivative using antibodies that bind specifically to denatured hemoglobin. His analysis device incorporates a unique design featuring a separation cavity that uses centrifugal force to differentiate the liquid components, thereby enhancing the efficiency of sample analysis.

Career Highlights

Hirotaka Tanaka has had an impressive career working with major companies in the electronics and technology sectors, most notably with Panasonic Corporation and Matsushita Electric Industrial Co., Ltd. His extensive experience at these esteemed organizations has played a crucial role in shaping his innovative approaches and methods in the analytical technology domain.

Collaborations

Throughout his career, Tanaka has worked alongside talented individuals, such as Fumihisa Kitawaki and Mie Takahashi. Collaborating with such skilled professionals has allowed him to combine talents and insights, fostering a creative environment that leads to groundbreaking inventions and patents.

Conclusion

Hirotaka Tanaka's contributions to the field of hemoglobin measurement and analytical reagent production demonstrate his dedication to innovation and excellence. With numerous patents under his belt, he continues to advance technology that enhances medical diagnostics and research, paving the way for more reliable health assessments. His journey serves as an inspiration for aspiring inventors and professionals in the scientific community.

Profile summary based on public USPTO records.